The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma.

Research paper by Francesco F Giammarile, Clare C Schilling, Gopinanth G Gnanasegaran, Chandrasckhar C Bal, Wim J G WJG Oyen, Domenico D Rubello, Thomas T Schwarz, Girolamo G Tartaglione, Rodolfo Nuñez RN Miller, Diana D Paez, Fijis W B FWB van Leeuwen, Renato A RA Valdés Olmos, Mark M McGurk, Roberto C RC Delgado Bolton

Indexed on: 20 Dec '18Published on: 20 Dec '18Published in: European Journal of Nuclear Medicine and Molecular Imaging


Sentinel lymph node biopsy is an essential staging tool in patients with clinically localized oral cavity squamous cell carcinoma. The harvesting of a sentinel lymph node entails a sequence of procedures with participation of specialists in nuclear medicine, radiology, surgery, and pathology. The aim of this document is to provide guidelines for nuclear medicine physicians performing lymphoscintigraphy for sentinel lymph node detection in patients with early N0 oral cavity squamous cell carcinoma. These practice guidelines were written and have been approved by the European Association of Nuclear Medicine (EANM) and the International Atomic Energy Agency (IAEA) to promote high-quality lymphoscintigraphy. The final result has been discussed by distinguished experts from the EANM Oncology Committee, and national nuclear medicine societies. The document has been endorsed by the Society of Nuclear Medicine and Molecular Imaging (SNMMI). These guidelines, together with another two focused on Surgery and Pathology (and published in specialised journals), are part of the synergistic efforts developed in preparation for the "2018 Sentinel Node Biopsy in Head and Neck Consensus Conference". The present practice guidelines will help nuclear medicine practitioners play their essential role in providing high-quality lymphatic mapping for the care of early N0 oral cavity squamous cell carcinoma patients.

More like this: